Richard J. Durbin headshot
At a Glance
Seat
U.S. Senator from Illinois
Born
November 21, 1944
Age 81
Phone
(202) 224-2152
Office
711 Hart Senate Office Building Washington, DC 20510, Washington 20515
Congress Member Profile|U.S. Senator|Democrat|Illinois

Richard J. Durbin

Voting Record — 890
Yes35%
No62%
Present0%
Not Voting3%
Party align93%
Cross-party6%
SoupScore
District Map

Senate District (Statewide)

U.S. Census Bureau boundary data.
Richard J. Durbin headshot
Richard J. Durbin
U.S. SenatorDemocratIllinois
SoupScore
Richard J.'s ATmosphere Activity
20 recent posts · 134 sponsored · 377 cosponsored
View profile

Recent ATmosphere posts, sponsorships, and cosponsorships.

At the root of our nursing shortage is too few faculty. I secured funding to help McKendree University launch a program to train nursing educators. This spring, the first class of master-level nurses will graduate. Yesterday, we celebrated this progress in supporting our rural nursing workforce.
Tens of thousands of cases, including investigations into drug trafficking, white-collar crime, and terrorism have been dropped by the Trump Administration to make way for its mass deportation campaign. Americans are less safe because of the President’s anti-immigrant agenda.
Tens of thousands of cases, including investigations into drug trafficking, white-collar crime, and terrorism have been dropped by the Trump Administration to make way for its mass deportation campaign. Americans are less safe because of the President’s anti-immigrant agenda.
BREAKING: DOJ dropped 23,000 criminal cases, including investigations into drugs and terrorism, in the Trump Administration’s first six months.
It’s outrageous: the U.S. and New Zealand are the only two developed nations that allow drug ads on TV. I joined Senator Marshall to urge FDA to review certain drug ads before they are aired so patients are not misled by the flood of deceptive telehealth & Big Pharma commercials.
Today, gas prices hit $4 a gallon, the highest price in nearly four years. President Trump’s war with Iran is costing Americans at home, & endangering our service members abroad. Yet Congressional Republicans want to give this Admin a blank check for a war that seems to have no end strategy.
I joined @duckworth.senate.gov to demand answers for why President Trump pulled America into a war with Iran, while at the same time easing sanctions on the very same adversary and Russia. This conflict is costing Americans money and service members their lives. We need answers now.
I joined Senator Blackburn to reintroduce our bipartisan Rural America Health Corps Act. This bill would provide new funding and support for rural communities so we can attract & retain doctors, nurses, physician assistants, dentists, & behavioral health specialists in every corner of our state.
Read my statement on the Senate passage of legislation to fund the U.S. Department of Homeland Security (DHS) with the exception of U.S. Immigration and Customs Enforcement (ICE).
The price of coffee, ground beef, and so many other groceries is through the roof because of Trump’s tariff tax. His economic policies are creating hardship and stress for millions of Americans.
Today, I met with Putnam & Clark County EMS chiefs Jackson and Bramlett to discuss how Congress can champion the work done by ambulance crews. I passed the SIREN Act in 2018 to fund equipment & recruitment for rural EMS agencies. I’m glad these grants are helping first responders answer the call.
Today, I spoke with Victor Peng, Interim CEO of PsiQuantum, about how the federal government can be a champion for quantum technology. Illinois is leading the charge when it comes to quantum computing, and it’s critical that we continue to invest in R&D to keep the momentum up.
Today, I met with Illinois State University President Dr. Aondover Tarhule to discuss ISU’s growth of STEM majors. Supporting STEM is one of the best investments we can make in our future, and I am committed to helping universities like ISU remain at the forefront of research and workforce training.
Pleased to see that the House Health Subcommittee is holding a hearing on my Prohibiting Tianeptine & Other Dangerous Products Act, which would protect consumers from dangerous ingredients in supplements. As the House considers this legislation, I urge my colleagues in the Senate to do the same.
Kash Patel could never be the qualified, diligent, and stable FBI Director that Robert Mueller was. I won’t let Director Mueller’s memory be tainted by a vengeful President and his loyalist lackey.
Georgia-Pacific is trying to use bankruptcy maneuvers to evade accountability. Its asbestos-containing products hurt thousands of victims. The Supreme Court must reject this ploy, or it could become a playbook for corporate scheming.
BREAKING: Sens. DURBIN, WHITEHOUSE, HAWLEY call on Supreme Court to reject corporations’ efforts to sidestep liability in mass tort cases.
Millions of Americans, including myself, participate in airline rewards programs. But these programs need oversight. I introduced the Protect Your Points Act to ensure that these programs remain transparent & that airlines cannot take advantage of customers through bait and switch tactics.
I met with leadership from the Morton Arboretum, located in DuPage County, to discuss how we can protect their 1,700 acres of forest and greenspace. We must preserve America’s forests so they may continue to play an essential role in both the environment and recreation for generations to come.
Congress isn’t doing much legislating these days. Protecting kids from the dangers of social media is popular and bipartisan. Just a suggestion for the Republican leaders.
SoupScore Breakdown
Loading analysis metrics…
Voting History
890 total votes
ExpandCollapse

Recent roll calls with party-majority context so it is easier to scan how this member tends to vote.

DateBillQuestionPositionParty MajAlign?Result
2025-10-01S. Res. 412 (119th)End debateNONOCloture Motion Agreed to (53-46)
2025-10-01Confirm nomineeNONONomination Confirmed (52-45)
2025-10-01End debateNONOCloture Motion Agreed to (52-47)
2025-10-01H.R. 5371 (119th)End filibuster to begin debateNONOCloture on the Motion to Proceed Rejected (55-45, 3/5 majority required)
2025-10-01S. 2882 (119th)End filibuster to begin debateYESYESCloture on the Motion to Proceed Rejected (47-53, 3/5 majority required)
2025-09-30H.R. 5371 (119th)Final passageNONOBill Defeated (55-45, 3/5 majority required)
2025-09-30S. 2882 (119th)Final passageYESYESBill Defeated (47-53, 3/5 majority required)
2025-09-29S. 2806 (119th)End filibuster to begin debateNONOCloture on the Motion to Proceed Rejected (37-61, 3/5 majority required)
2025-09-29Confirm nomineeNONONomination Confirmed (54-45)
2025-09-29End debateNONOCloture Motion Agreed to (54-45)
2025-09-19Confirm nomineeNOT_VOTINGNONomination Confirmed (47-43)
2025-09-19End debateNONOCloture Motion Agreed to (47-45)
2025-09-19H.R. 5371 (119th)Final passageNONOBill Defeated (44-48, 3/5 majority required)
2025-09-19S. 2882 (119th)Final passageYESYESBill Defeated (47-45, 3/5 majority required)
2025-09-18Confirm nomineeNONONomination Confirmed (51-47)
2025-09-17End debateNONOCloture Motion Agreed to (52-47)
2025-09-17Decision of the Chair PN12-19 and PN25-28 and PN12-45 and PN22-1 and PN22-2 and PN22-5 and PN22-27 and PN22-20 and PN22-21 and PN26-8 and PN26-34 and PN26-35 and PN55-41 and PN22-4 and PN22-8 and PN22-19 and PN26-1 and PN22-23 and PN25-40 and PN26-7 and PN26-19 and PN26-31 and PN60-3 and PN26-44 and PN25-2 and PN55-16 and PN60-9 and PN60-10 and PN129-8 and PN26-45 and PN141-37 and PN141-7 and PN141-28 and PN12-22 and PN25-21 and PN22-3 and PN26-22 and PN13-5 and PN22-24 and PN25-33 and PN141-18 and PN150-5 and PN345-16 and PN55-42 and PN54-6 and PN54-7 and PN55-45 and PN55-25YESYESDecision of Chair Not Sustained (47-52)
2025-09-17Motion to Reconsider PN55-25 and PN55-45 and PN54-7 and PN54-6 and PN55-42 and PN345-16 and PN150-5 and PN141-18 and PN25-33 and PN22-24 and PN13-5 and PN26-22 and PN22-3 and PN25-21 and PN12-22 and PN141-28 and PN141-7 and PN141-37 and PN26-45 and PN129-8 and PN60-10 and PN60-9 and PN55-16 and PN25-2 and PN26-44 and PN60-3 and PN26-31 and PN26-19 and PN26-7 and PN25-40 and PN22-23 and PN26-1 and PN22-19 and PN22-8 and PN22-4 and PN55-41 and PN26-35 and PN26-34 and PN26-8 and PN22-21 and PN22-20 and PN22-27 and PN22-5 and PN22-2 and PN22-1 and PN12-45 and PN12-19 and PN25-28NONOMotion to Reconsider Agreed to (51-47)
2025-09-17End debateNONOCloture Motion Rejected (51-48, 3/5 majority required)
2025-09-16S. Con. Res. 22 (119th)Begin considerationNONOMotion to Proceed Rejected (36-62)
2025-09-16S.J. Res. 60 (119th)Begin considerationYESYESMotion to Proceed Rejected (47-51)
2025-09-15Confirm nomineeNONONomination Confirmed (48-47)
2025-09-15End debateNONOCloture Motion Agreed to (50-44)
2025-09-15S. Res. 377 (119th)Approve resolutionNONOResolution Agreed to (51-44)
2025-09-11S. Res. 377 (119th)End debateNONOCloture Motion Agreed to (53-43)
2025-09-11S. Res. 377 (119th)Decision of the Chair S.Res. 377YESYESDecision of Chair Not Sustained (45-53)
2025-09-11S. Res. 377 (119th)Motion to Reconsider S.Res. 377NONOMotion to Reconsider Agreed to (52-45)
2025-09-11S. Res. 377 (119th)End debateNONOCloture Motion Rejected (52-47, 3/5 majority required)
2025-09-10S. 2296 (119th)Kill the motionNONOMotion to Table Agreed to (51-49)
2025-09-09S. Res. 377 (119th)Begin considerationNONOMotion to Proceed Agreed to (53-45)
2025-09-09S. Res. 377 (119th)Kill the motionNONOMotion to Table Agreed to (53-46)
2025-09-09Confirm nomineeNONONomination Confirmed (53-45)
2025-09-09End debateNONOCloture Motion Agreed to (53-44)
2025-09-09Confirm nomineeNONONomination Confirmed (49-46)
2025-09-09End debateNONOCloture Motion Agreed to (51-46)
2025-09-09Confirm nomineeNONONomination Confirmed (52-45)
2025-09-08Confirm nomineeNONONomination Confirmed (50-43)
2025-09-04S. 2296 (119th)Begin considerationYESYESMotion to Proceed Agreed to (83-13)
2025-09-04End debateNONOCloture Motion Agreed to (53-46)
2025-09-04End debateNONOCloture Motion Agreed to (53-45)
2025-09-02S. 2296 (119th)End filibuster to begin debateYESYESCloture on the Motion to Proceed Agreed to (84-14, 3/5 majority required)
2025-08-02Confirm nomineeYESNONomination Confirmed (71-23)
2025-08-02Confirm nomineeYESNomination Confirmed (72-22)
2025-08-02Confirm nomineeNONONomination Confirmed (59-35)
2025-08-02Confirm nomineeNONONomination Confirmed (52-42)
2025-08-02Confirm nomineeNONONomination Confirmed (50-45)
2025-08-02Confirm nomineeYESYESNomination Confirmed (78-17)
2025-08-02End debateYESYESCloture Motion Agreed to (76-19)
2025-08-02Confirm nomineeNONONomination Confirmed (50-45)
2025-08-02End debateNONOCloture Motion Agreed to (51-45)

Alignment stats consider only votes where a clear yes/no majority existed for the legislator's party. Cross-party marks divergence where the vote matched the opposite party majority. ↔ indicates cross-party divergence.

← PrevPage 8 / 18Next →